Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Simon Salerno

Neurological Surgery Wall Township, NJ Medical Doctor

NPI 1962455303 CMS profile 43345

2101 Route 34, Wall Township, NJ 07719

Open in the dashboard

General payments

$275,224

842 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$83,557

4 holdings reported · through program year 2025

Research they led as principal investigator

$4,204 paid to institutions, not to them · program year 2019

Through program year 2025, Simon Salerno of Wall Township, NJ is reported in the CMS Open Payments database as having received $275,224 across 842 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $4,204 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $83,557 across 4 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $27,914 111
2024 General $51,762 118
2023 General $31,533 132
2022 General $62,412 115
2021 General $47,591 135
2020 General $5,212 67
2019 General $48,800 164
2025 Ownership $30,841 1
2024 Ownership $23,165 1
2023 Ownership $16,351 1
2022 Ownership $13,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Simon Salerno
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Simon Salerno were reported at $27,914. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Simon Salerno Neurological Surgery median Middle half National median
2019 $48,800 $582 $138–$3,006 $163
2020 $5,212 $294 $76–$2,174 $114
2021 $47,591 $387 $105–$2,432 $132
2022 $62,412 $542 $139–$2,989 $149
2023 $31,533 $534 $145–$2,697 $160
2024 $51,762 $574 $155–$3,046 $164
2025 $27,914 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $84,575 81 payments
  2. Stryker Corporation $36,113 65 payments
  3. Medtronic, Inc. $31,950 83 payments
  4. Exapnding Innovations, Inc. $31,653 10 payments
  5. SI-BONE, Inc. $21,584 51 payments
  6. Kuros Biosciences USA, Inc $8,392 13 payments
  7. Nevro Corp. $8,320 79 payments
  8. Alphatec Spine, Inc $6,060 29 payments
  9. NuVasive, Inc. $5,899 98 payments
  10. Ethicon US, LLC $5,001 2 payments
  11. Other $35,679 331 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $96,573 39 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $71,088 23 payments
  3. Travel and Lodging $43,849 120 payments
  4. Food and Beverage $32,956 637 payments
  5. Royalty or License $25,132 12 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,038 2 payments
  7. Honoraria $1,500 1 payment
  8. Education $1,089 8 payments
Products named General payments · program years 2019–2025
  1. RISE-L $30,035 13 payments
  2. NIAGARA LATERAL ACCESS SYSTEM $20,947 4 payments
  3. CASCADIA INTERBODY SYSTEM $16,808 8 payments
  4. X-PAC $14,010 3 payments
  5. IFUSE IMPLANT $11,743 31 payments
  6. INTELLIS $11,727 6 payments
  7. ELSA ATP $10,541 7 payments
  8. ELSA $9,775 4 payments
  9. IFUSE IMPLANT SYSTEM $8,774 8 payments
  10. INTELLIS ADAPTIVESTIM $8,730 17 payments
  11. Other $151,282 731 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

41

Median for Neurosurgery: 83

Drug cost

$359

Median for Neurosurgery: $872

Branded share of claims

0%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 30 $307
Oxycodone Hcl Generic 11 $52

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 102 billing codes

Paid by Medicare

$376,286

Medicare's payments for the services billed

Medicare patients

418

Average age 72

Services billed

1,398

247 women, 171 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 44%
Depression 37%
Diabetes 35%
Chronic kidney disease 26%
Osteoporosis 23%
COPD 22%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

842 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in New Jersey

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record